Cardio Diagnostics Holdings, Inc. (CDIO) Secures Medicare Pricing Approval for Precision Cardiovascular Tests

Insider Monkey12-18

We recently compiled a list of the Top 12 AI Stock News and Ratings Dominating Wall Street. In this article, we are going to take a look at where Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) stands...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2492975912?lang=en_US&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/gD6eYu3rwljxScuJtlsg7g--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/310e6c70ba2085347c3a5856d6c13233","is_english":true,"pubTime":"2024-12-18 15:03","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2492975912","market":"us","top_or_hot":-1,"title":"Cardio Diagnostics Holdings, Inc. (CDIO) Secures Medicare Pricing Approval for Precision Cardiovascular Tests","media":"Insider Monkey","content":"<div>\n<p>We recently compiled a list of the Top 12 AI Stock News and Ratings Dominating Wall Street. In this article, we are going to take a look at where Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) stands...</p>\n\n<a href=\"https://finance.yahoo.com/news/cardio-diagnostics-holdings-inc-cdio-070325467.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cardio Diagnostics Holdings, Inc. (CDIO) Secures Medicare Pricing Approval for Precision Cardiovascular Tests</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCardio Diagnostics Holdings, Inc. (CDIO) Secures Medicare Pricing Approval for Precision Cardiovascular Tests\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-18 15:03 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/cardio-diagnostics-holdings-inc-cdio-070325467.html><strong>Insider Monkey</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>We recently compiled a list of the Top 12 AI Stock News and Ratings Dominating Wall Street. In this article, we are going to take a look at where Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) stands...</p>\n\n<a href=\"https://finance.yahoo.com/news/cardio-diagnostics-holdings-inc-cdio-070325467.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU2089283258.USD","symbol_name":"安联环球可持续基金Cl AM Dis","start_time":0,"source_url":"https://finance.yahoo.com/news/cardio-diagnostics-holdings-inc-cdio-070325467.html","article_id":"2492975912","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/gD6eYu3rwljxScuJtlsg7g--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/310e6c70ba2085347c3a5856d6c13233"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2492975912","pubTimestamp":1734505405,"columns":[],"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"We recently compiled a list of the Top 12 AI Stock News and Ratings Dominating Wall Street.In this article, we are going to take a look at where Cardio Diagnostics Holdings, Inc. stands against the other AI stocks.There is a growing concern in Silicon Valley that the progress around artificial intelligence is slowly “losing steam”. CNBC’s Deirdre Bosa explores whether AI progress is slowing, and what it means for the industry. Early signs of struggle are bubbling up in major tech names. As highlighted by Bosa, the first sign of things slowing down has been a lack of progression between models. OpenAI has led the pack in AI advancements, with each of the new models of ChatGPT exponentially better than the last.“While Orion’s performance ended up exceeding that of prior models, the increase in quality was far smaller compared with the jump between GPT-3 and GPT-4, the last two flagship models the company released, according to some OpenAI employees who have used or tested Orion”.","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU2089283258.USD":"安联环球可持续基金Cl AM Dis","LU1778281490.HKD":"HSBC GIF GLOBAL LOWER CARBON EQUITY \"AD\" (HKD) INC","LU0130103400.USD":"Natixis Harris Associates Global Equity RA USD","LU0708995401.HKD":"FRANKLIN U.S. OPPORTUNITIES \"A\" (HKD) ACC","IE00BKVL7J92.USD":"Legg Mason ClearBridge - US Equity Sustainability Leaders A Acc USD","LU1201861165.SGD":"Natixis Harris Associates Global Equity PA SGD","GOOGL":"谷歌A","BK4538":"云计算","SG9999014880.SGD":"大华全球优质成长基金Acc SGD","LU0211328371.USD":"TEMPLETON GLOBAL EQUITY INCOME \"A\" (MDIS) (USD)   INC","CHD":"丘奇＆德怀特","LU0476273544.USD":"CT (LUX) I GLOBAL TECHNOLOGY \"BU\" (USD) ACC","LU1923623000.USD":"Natixis Thematics AI & Robotics Fund R/A USD","BK4208":"复合型公用事业","LU1116320901.HKD":"BGF SYSTEMATIC GLOBAL ENHANCED EQUITY YIELD \"A6\" (HKD) INC","LU0943347566.SGD":"安联收益及增长平衡基金AM H2-SGD","BK4574":"无人驾驶","LU1429558221.USD":"Natixis Loomis Sayles US Growth Equity RA USD","LU2491050071.SGD":"WELLINGTON SUSTAINABLE OUTCOMES \"A\" (SGDHDG) ACC","LU1988902786.USD":"FULLERTON LUX FUNDS GLOBAL ABSOLUTE ALPHA \"I\" (USD) ACC","IE0004091025.USD":"BNY MELLON GLOBAL OPPORTUNITIES \"B\" (USD) ACC","LU0048573561.USD":"FIDELITY AMERICA \"A\" (USD) INC","CMS":"CMS能源","LU2360032135.SGD":"ALLSPRING GLOBAL EQUITY ENHANCED INCOME \"A\" (SGDHDG) INC","LU2244417387.USD":"FIDELITY SUSTAINABLE US EQUITY \"A\" (USD) ACC","BK4533":"AQR资本管理(全球第二大对冲基金)","CDIO":"CARDIO DIAGNOSTICS HOLDINGS INC","LU0640476718.USD":"THREADNEEDLE (LUX) US CONTRARIAN CORE EQ \"AU\" (USD) ACC","LU0048584097.USD":"FIDELITY FUNDS  GLOBAL THEMATIC OPPORTUNITIES \"A\" (USD) INC","SGXZ51526630.SGD":"大华环球创新基金A Acc SGD","LU2089284900.SGD":"Allianz Global Sustainability Cl AM Dis H2-SGD","LU1084165304.USD":"FIDELITY WORLD \"A\" (USD) ACC","IE00BSNM7G36.USD":"NEUBERGER BERMAN SYSTEMATIC GLOBAL SUSTAINABLE VALUE \"A\" (USD) ACC","LU1221951046.USD":"NORDEA 1 STABLE RETURN \"HM\" (USDHDG) INC","LU0820561909.HKD":"ALLIANZ INCOME AND GROWTH \"AM\" (HKD) INC","LU0345774631.USD":"NINETY ONE GSF AMERICAN FRANCHISE \"A\" (USD) INC","LU1894683264.USD":"AMUNDI FUNDS US EQUITY RESEARCH VALUE \"A2\" (USD) ACC","LU1868836757.USD":"CT (LUX) I AMERICAN FUND \"2\" (USD) ACC","LU0314104364.USD":"MANULIFE GF AMERICAN GROWTH \"AA\" (USD) INC","LU0345770308.USD":"NINETY ONE GSF GLOBAL STRATEGIC EQUITY \"A\" (USD) ACC","IE00BWXC8680.SGD":"PINEBRIDGE US LARGE CAP RESEARCH ENHANCED \"A5\" (SGD) ACC","CDIOW":"CARDIO DIAGNOSTICS HOLDINGS INC C/WTS (01/12/2026) TO PUR COM","BK4018":"居家用品","LU0345769128.USD":"NINETY ONE GSF GLOBAL EQUITY \"A\" (USD) ACC","LU2087625088.SGD":"ALLSPRING  US ALL CAP GROWTH \"A\" (SGDHDG) ACC","LU1267930573.SGD":"TEMPLETON GLOBAL \"AA\" (SGD) ACC A","LU0106261372.USD":"SCHRODER ISF US LARGE CAP \"A\" ACC","CSII":"Cardiovascular Systems","LU0215105999.USD":"SCHRODER ISF GLOBAL EQUITY \"A\" ACC","LU0225283273.USD":"SCHRODER ISF GLOBAL EQUITY ALPHA \"A\" (USD) ACC"},"translate_title":"Cardio Diagnostics Holdings，Inc.(CDIO)获得Medicare对精确心血管测试的定价批准","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CDIO":1,"CHD":1,"CMS":1,"CSII":1,"CDIOW":0.9,"GOOGL":0.62},"content_text":"We recently compiled a list of the Top 12 AI Stock News and Ratings Dominating Wall Street. In this article, we are going to take a look at where Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) stands against the other AI stocks.\nThere is a growing concern in Silicon Valley that the progress around artificial intelligence is slowly “losing steam”. CNBC’s Deirdre Bosa explores whether AI progress is slowing, and what it means for the industry. Early signs of struggle are bubbling up in major tech names. As highlighted by Bosa, the first sign of things slowing down has been a lack of progression between models. OpenAI has led the pack in AI advancements, with each of the new models of ChatGPT exponentially better than the last.\nREAD NOW: 10 AI Stocks Taking Wall Street by Storm and Top 10 AI Stocks on Latest News and Analyst Ratings\nUnfortunately, the same can’t be said about today. OpenAI's highly anticipated model Orion was expected to be a ground-breaking system bringing us closer to AGI. However, the initial vision is being scaled back.\n\n“While Orion’s performance ended up exceeding that of prior models, the increase in quality was far smaller compared with the jump between GPT-3 and GPT-4, the last two flagship models the company released, according to some OpenAI employees who have used or tested Orion”.\n-The Information\n\nThe same roadblocks have been happening to other AI models, such as that by Anthropic. Just like OpenAI, Anthropic is also witnessing a timetable slip for the release of its long-awaited Claude model called 3.5 Opus.\n\n\"The AGI bubble is bursting a little bit. It's become clear that 'different training approaches' may be needed to make AI models work really well on a variety of tasks.\"\n-Margaret Mitchell, chief ethics scientist at AI startup Hugging Face, to Bloomberg.\n\nEven some of the big tech giants aren't enthusiastic about the progress AI has been making. Speaking during the New York Times annual DealBook summit at Jazz at Lincoln Center, Sundar Pichai stated how generative AI won’t be changing lives in 2025— at least, not more than it already has.\n\n“I think the progress is going to get harder. When I look at [2025], the low-hanging fruit is gone. The hill is steeper ... You’re definitely going to need deeper breakthroughs as we get to the next stage”.\n- Sundar Pichai\n\nHowever, if progress is plateauing, it has to do with scaling laws. Anthropic CEO Dario Amodei states that the scaling laws are a misnomer. He emphasizes that while these patterns have historically guided AI development—suggesting that increasing data and computational power leads to improved AI capabilities—they are not guaranteed to continue indefinitely.\nAs such, AI companies have been turning to synthetic AI, i.e. data generated artificially. The Information reports that Orion was produced based on synthetic data. However, the problem has been that low-quality data, in turn, leads to low-quality performance. As such, with leading tech companies poised to unveil new models over the next eighteen months, their pace of progress—or lack thereof—has the potential to dramatically redefine the dynamics of the competition.\nFor this article, we selected AI stocks by going through news articles, stock analysis, and press releases. These stocks are also popular among hedge funds.\nWhy are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points (see more details here).\n A doctor delivering the results of an epigenetics-based clinical test to a patient. \nCardio Diagnostics Holdings, Inc. (NASDAQ:CDIO)\nNumber of Hedge Fund Holders: 3\nCardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) is an AI-driven precision cardiovascular medicine company that makes heart disease prevention more accessible, personalized, and precise. On December 16, the company announced that two of their tests had received final pricing determinations from the Centers for Medicare & Medicaid Services (CMS). Effective January 1, 2025, Medicare contractors will be able to determine pricing for PrecisionCHD and Epi+Gen CHD tests based on actual cost data from Cardio Diagnostics. The approval allows these tests to be accessible to the Medicare population.\n\n“Receiving this final determination is a crucial step for our innovative solutions to help improve the risk assessment, diagnosis, management and monitoring of coronary heart disease (CHD) for Medicare patients. This milestone brings us closer to addressing the significant unmet needs in cardiovascular care for the Medicare population, enabling clinicians to better personalize treatment strategies and ultimately improve patient outcomes”.\n-Meesha Dogan, Ph.D., CEO and Co-Founder of Cardio Diagnostics.\n\nOverall CDIO ranks 11th on our list of the AI stocks that are dominating Wall Street. While we acknowledge the potential of CDIO as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than CDIO but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.   \nREAD NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock.   \nDisclosure: None. This article is originally published at Insider Monkey.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2492975912"}